Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Larson

Showing results (1311-1320 of 1,352) with videos related to

Pageof 136
Sort By:
Journal of Hematology & Oncology|November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignanciesKim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancerAndrew M Scott, Greg Wiseman, Sydney Welt, et al.
Molecular Cancer Therapeutics|October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal CarcinomatosisChristopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2025
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib StudyKerry A Rogers, Pearlly Yan, Ian W Flinn, et al.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|May 1, 2012
The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33)Nicholas G H Mohtadi, Damian R Griffin, M Elizabeth Pedersen, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Nature Communications|February 17, 2026
Exponential crystallization in coralsZoë Rechav, Eric Tambutté, Isabelle M LeCloux, et al.
Pageof 136

Showing results (1311-1320 of 1,352) with videos related to

Sort By:
Pageof 136
Journal of Hematology & Oncology|November 12, 2022
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignanciesKim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancerAndrew M Scott, Greg Wiseman, Sydney Welt, et al.
Molecular Cancer Therapeutics|October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal CarcinomatosisChristopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2025
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib StudyKerry A Rogers, Pearlly Yan, Ian W Flinn, et al.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|May 1, 2012
The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33)Nicholas G H Mohtadi, Damian R Griffin, M Elizabeth Pedersen, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Nature Communications|February 17, 2026
Exponential crystallization in coralsZoë Rechav, Eric Tambutté, Isabelle M LeCloux, et al.
Pageof 136